Who
Emily English
Chief Operations Officer
Company insider
Files Form 4 as: Chief Operations Officer, Cartesian Therapeutics.
In numbers
- Trades disclosed
- 20
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $30K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 26 Dec 2024
- Last trade
- 2 Jan 2026
- Last filed
- 6 Jan 2026
Companies traded
Activity over time
1 Dec 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Jan 2026filed 6 Jan 2026 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Code A | —24,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —71,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —71,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Code A | —24,000 at $0.00 | filing |
| 30 Dec 2025filed 2 Jan 2026 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Code M | $25K7,500 at $3.30 | filing |
| 30 Dec 2025filed 2 Jan 2026 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,500 | filing |
| 30 Dec 2025filed 2 Jan 2026 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,500 | filing |
| 30 Dec 2025filed 2 Jan 2026 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Code M | $25K7,500 at $3.30 | filing |
| 28 Nov 2025filed 2 Dec 2025 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,500 | filing |
| 28 Nov 2025filed 2 Dec 2025 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Code M | $25K7,500 at $3.30 | filing |
| 12 May 2025filed 14 May 2025 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,500 | filing |
| 12 May 2025filed 14 May 2025 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Code M | $25K7,500 at $3.30 | filing |
| 15 Apr 2025filed 16 Apr 2025 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,500 | filing |
| 15 Apr 2025filed 16 Apr 2025 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Code M | $25K7,500 at $3.30 | filing |
| 6 Jan 2025filed 7 Jan 2025 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Sold | $15K906 at $16.83 | filing |
| 3 Jan 2025filed 7 Jan 2025 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Sold | $15K891 at $16.72 | filing |
| 2 Jan 2025filed 6 Jan 2025 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —47,400 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Code A | —16,100 at $0.00 | filing |
| 26 Dec 2024filed 30 Dec 2024 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,650 | filing |
| 26 Dec 2024filed 30 Dec 2024 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Code M | $25K7,650 at $3.30 | filing |
News
No headline names them, or the companies they trade most, lately.